New perspectives on the course and treatment of bipolar disorder

Minerva Psichiatrica

Volumn 58, Issue 1, 2017, Pages 40-53

  Post, Robert M ^a  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Comorbidity; Epigenesis; Genetic; Psychopharmacology

Indexed keywords

ANTIDEPRESSANT AGENT; LITHIUM;

ALCOHOL ABUSE; ANXIETY DISORDER; BIPOLAR DISORDER; BRAIN DEPTH STIMULATION; CENTRAL NERVOUS SYSTEM SENSITIZATION; COMORBIDITY; DISEASE COURSE; DRUG DEPENDENCE; EPIGENETICS; FAMILY HISTORY; HUMAN; INCIDENCE; KINDLING; NONHUMAN; PREVALENCE; REVIEW; SEIZURE; SOCIAL PSYCHOLOGY; SUBSTANCE USE;

EID: 85017383519     PISSN: 03911772     EISSN: 18271731     Source Type: Journal    
DOI: 10.23736/S0391-1772.17.01921-5     Document Type: Review

References (75)

1. Kraepelin E. Manic-depressive insanity and paranoia. Edinburgh: E& SLivingstone; 1921.
2. Kessing LV, Hansen MG, Andersen PK. Course of illness in depressive and bipolar disorders. Naturalistic study, 1994-1999. Br J Psychiatry 2004;185:372-7.
3. Kessing LV, Andersen PK. Predictive effects of previous episodes on the risk of recurrence in depressive and bipolar disorders. Curr Psychiatry Rep 2005;7:413-20.
4. Post RM. Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am J Psychiatry 1992;149:999-1010.
5. Post RM. Kindling and sensitization as models for affective episode recurrence, cyclicity, and tolerance phenomena. Neurosci Biobehav Rev 2007;31:858-73.
6. Post R. Recognizing depression, anxiety, and externalizing behaviors in children of a parent with mood disorders. J Depress Anxiety 2016a; S2.
7. Post R. Children in the us are at high risk for psychiatric disorders: Early monitoring by parents may enhance awareness and treatment. J Pediatr Neurol Med 2016b;3.
8. Kendler KS, Thornton LM, Gardner CO. Stressful life events and previous episodes in the etiology of major depression in women: An evaluation of the "kindling" hypothesis. Am J Psychiatry 2000;157:1243-51.
9. Kendler KS, Thornton LM, Gardner CO. Genetic risk, number of previous depressive episodes, and stressful life events in predicting onset of major depression. Am J Psychiatry 2001;158:582-6.
10. Post RM, Kalivas P. Bipolar disorder and substance misuse: Pathological and therapeutic implications of their comorbidity and cross-sensitisation. Br J Psychiatry 2013;202:172-6.
11. Post RM, Leverich GS, Altshuler LL, Frye MA, Suppes T, Mcelroy SL, et al. Relationship of prior antidepressant exposure to long-Term prospective outcome in bipolar idisorder outpatients. J Clin Psychiatry 2012;73:924-30.
12. Post RM, Altshuler LL, Kupka R, Mcelroy SL, Frye MA, Rowe M, et al. Age of onset of bipolar disorder: combined effect of childhood adversity and familial loading of psychiatric disorders. J Psychiatr Res 2016;81:63-70.
13. Post RM, Altshuler LL, Kupka R, Mcelroy SL, Frye MA, Rowe M, et al. More illness in offspring of bipolar patients from the U.S. Compared to europe. J Affect Disord 2016;191:180-6.
14. Goddard GV, Mcintyre DC, Leech CK. Apermanent change in brain function resulting from daily electrical stimulation. Exp Neurol 1969;25:295-330.
15. Racine R. Kindling: The first decade. Neurosurgery 1978;3:234-52.
16. Post R, Weiss SR, Pert A, Uhde T. Chronic cocaine administration: Sensitization and kindling effects. In: Raskin A, Fisher S, editors. Cocaine: Clinical and biobehavioral aspects. New York: Oxford University Press; 1987:109-73.
17. Ballenger JC, Post RM. Therapeutic effects of carbamazepine in affective illness: Apreliminary report. Commun Psychopharmacol 1978;2:159-75.
18. Post RM. Animal models of mood disorders: Kindling as model of affective illness progression. Behavioral aspects of epilepsy: Principles and practice. New York: Demos 2008:19-27.
19. Pinel JP. Effects of diazepam and diphenylhydantoin on elicited and spontaneous seizures in kindled rats: Adouble dissociation. Pharmacol Biochem Behav 1983;18:61-3.
20. Post RM, Fleming J, Kapczinski F. Neurobiological correlates of illness progression in the recurrent affective disorders. J Psychiatr Res 2012;46:561-73.
21. Kessing LV, Vradi E, Andersen PK. Starting lithium prophylaxis early v. Late in bipolar disorder. Br J Psychiatry 2014;205:214-20.
22. Post RM, Leverich GS. Treatment of bipolar illness: Acasebook for clinicians and patients. New York, NY: WW Norton & Company, Inc; 2008.
23. Chaudhry HR, Kahn RM, Shabbir A, Mufti KA. Nimodipine in the treatment of bipolar disorder. Society of Biological Psychiatry. New Orleans, Louisiana; 2010:232S.
24. Post RM. Epigenetic basis of sensitization to stress, affective episodes, and stimulants: Implications for illness progression and prevention. Bipolar Disord 2016;18:315-24.
25. Roth TL, Lubin FD, Funk AJ, Sweatt JD. Lasting epigenetic influence of early-life adversity on the bdnf gene. Biol Psychiatry 2009;65:760-9.
26. Anier K, Malinovskaja K, Aonurm-Helm A, Zharkovsky A, Kalda A. DNA methylation regulates cocaine-induced behavioral sensitization in mice. Neuropsychopharmacology 2010;35:2450-61.
27. Berton O, Mcclung CA, Dileone RJ, Krishnan V, Renthal W, Russo SJ, et al. Essential role of bdnf in the mesolimbic dopamine pathway in social defeat stress. Science 2006;311:864-8.
28. Tsankova N, Renthal W, Kumar A, Nestler EJ. Epigenetic regulation in psychiatric disorders. Nat Rev Neurosci 2007;8:355-67.
29. Krishnan V, Han MH, Graham DL, Berton O, Renthal W, Russo SJ, et al. Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell 2007;131:391-404.
30. Weaver IC, Cervoni N, Champagne FA, D'alessio AC, Sharma S, Seckl JR, et al. Epigenetic programming by maternal behavior. Nat Neurosci 2004;7:847-54.
31. Meaney MJ, Aitken DH, Bodnoff SR, Iny LJ, Tatarewicz JE, Sapolsky RM. Early postnatal handling alters glucocorticoid receptor concentrations in selected brain regions. Behav Neurosci 2013;127:637-41.
32. Meaney MJ, Ferguson-Smith AC. Epigenetic regulationof the neural transcriptome: The meaning of the marks. Nat Neurosci 2010;13:1313-8.
33. Mcgowan PO, Sasaki A, D'alessio AC, Dymov S, Labonte B, Szyf M, et al. Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat Neurosci 2009;12:342-8.
34. Bale TL. Lifetime stress experience: Transgenerational epigenetics and germ cell programming. Dialogues Clin Neurosci 2014;16:297-305.
35. Rodgers AB, Bale TL. Germ cell origins of posttraumatic stress disorder risk: The transgenerational impact of parental stress experience. Biol Psychiatry 2015;78:307-14.
36. Szutorisz H, Dinieri JA, Sweet E, Egervari G, Michaelides M, Carter JM, et al. Parental thc exposure leads to compulsive heroin-seeking and altered striatal synaptic plasticity in the subsequent generation. Neuropsychopharmacology 2014;39:1315-23.
37. Byrnes JJ, Johnson NL, Schenk ME, Byrnes EM. Cannabinoid exposure in adolescent female rats induces transgenerational effects on morphine conditioned place preference in male offspring. J Psychopharmacol 2012;26:1348-54.
38. Vassoler FM, White SL, Schmidt HD, Sadri-Vakili G, Pierce RC. Epigenetic inheritance of a cocaine-resistance phenotype. Nat Neurosci 2013;16:42-7.
39. Gapp K, Von Ziegler L, Tweedie-Cullen RY, Mansuy IM. Early life epigenetic programming and transmission of stress-induced traits in mammals: how and when can environmental factors influence traits and their transgenerational inheritance? Bioessays 2014;36:491-502.
40. Dias BG, Ressler KJ. Parental olfactory experience influences behavior and neural structure in subsequent generations. Nat Neurosci 2014;17:89-96.
41. Post RM, Kupka R, Keck PE Jr., Mcelroy SL, Altshuler LL, Frye MA, et al. Further evidence of a cohort effect in bipolar disorder: More early onsets and family history of psychiatric illness in more recent epochs. J Clin Psychiatry 2016;77:1043-9.
42. Post RM, Altshuler L, Kupka R, Mcelroy S, Frye MA, Rowe M, et al. More pernicious course of bipolar disorder in the united states than in many european countries: Implications for policy and treatment. J Affect Disord 2014;160:27-33.
43. Post RM, Altshuler L, Kupka R, Mcelroy S, Frye M, Rowe M, et al. More childhood onset bipolar disorder in the united states than canada or europe: Implications for treatment and prevention. Neurosci Biobehav Rev 2017;74:204-13.
44. Post RM, Altshuler LL, Leverich GS, Frye MA, Suppes T, Mcelroy SL, et al. Role of childhood adversity in the development of medical co-morbidities associated with bipolar disorder. J Affect Disord 2013;147:288-94.
45. Post RM, Altshuler L, Kupka R, Mcelroy SL, Frye MA, Rowe M, et al. Multigenerational positive family history of psychiatric disorders is associated with a poor prognosis in bipolar disorder. J Neuropsychiatry Clin Neurosci 2015;27:304-10.
46. Post RM, Altshuler LL, Kupka R, Mcelroy SL, Frye MA, Rowe M, et al. Verbal abuse, like physical and sexual abuse, in childhood is associated with an earlier onset and more difficult course of bipolar disorder. Bipolar Disord 2015;17:323-30.
47. Axelson D, Goldstein B, Goldstein T, Monk K, Yu H, Hickey MB, et al. Diagnostic precursors to bipolar disorder in offspring of parents with bipolar disorder: A longitudinal study. Am J Psychiatry 2015;172:638-46.
48. Post RM. Clinical staging in bipolar disorder: Ahistorical perspective. In: Kapczinski F, editor. New York: Oxford University Press; 2015.
49. Post RM. Mechanisms of sensitization to stress, affective episodes, and abused substances: Implications for treatment and prevention. Neurobiology of addictions. New York: Oxford University Press; 2016:315-46.
50. Berk M, Brnabic A, Dodd S, Kelin K, Tohen M, Malhi GS, et al. Does stage of illness impact treatment response in bipolar disorder? Empirical treatment data and their implication for the staging model and early intervention. Bipolar Disord 2011;13:87-98.
51. Post RM, Chang K, Frye MA. Paradigm shift: preliminary clinical categorization of ultrahigh risk for childhood bipolar disorder to facilitate studies on prevention. J Clin Psychiatry 2013;74:167-9.
52. Post RM. Treatment of bipolar depression: Evolving recommendations. Psychiatr Clin North Am 2016;39:11-33.
53. Miklowitz DJ, Schneck CD, Singh MK, Taylor DO, George EL, Cosgrove VE, et al. Early intervention for symptomatic youth at risk for bipolar disorder: A randomized trial of family-focused therapy. J Am Acad Child Adolesc Psychiatry 2013;52:121-31.
54. Hudziak JJ, Albaugh MD, Ducharme S, Karama S, Spottswood M, Crehan E, et al. Cortical thickness maturation and duration of music training: Health-promoting activities shape brain development. J Am Acad Child Adolesc Psychiatry 2014;53: 1153-61, .
55. Birmaher B, Axelson D, Monk K, Kalas C, Goldstein B, Hickey MB, et al. Lifetime psychiatric disorders in school-Aged offspring of parents with bipolar disorder: The pittsburgh bipolar offspring study. Arch Gen Psychiatry 2009;66:287-96.
56. Kowatch RA, Suppes T, Carmody TJ, Bucci JP, Hume JH, Kromelis M, et al. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 2000;39:713-20.
57. Kowatch RA, Sethuraman G, Hume JH, Kromelis M, Weinberg WA. Combination pharmacotherapy in children and adolescents with bipolar disorder. Biol Psychiatry 2003;53:978-84.
58. Geller B, Luby JL, Joshi P, Wagner KD, Emslie G, Walkup JT, et al. Arandomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar i disorder, manic or mixed phase, in children and adolescents. Arch Gen Psychiatry 2012;69:515-28.
59. Findling RL, Mcnamara NK, Youngstrom EA, Stansbrey R, Gracious BL, Reed MD, et al. Double-blind 18-month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. J Am Acad Child Adolesc Psychiatry 2005;44:409-17.
60. Post RM, Altshuler L, Leverich G, Nolen W, Kupka R, Grunze H, et al. More stressors prior to and during the course of bipolar illness in patients from the united states compared with the netherlands and germany. Psychiatry Res 2013;210:880-6.
61. Kessing LV, Hansen HV, Hvenegaard A, Christensen EM, Dam H, Gluud C, et al. Treatment in a specialised out-patient mood disorder clinic v. Standard out-patient treatment in the early course of bipolar disorder: Randomised clinical trial. Br J Psychiatry 2013;202:212-9.
62. Yatham L. Can early intervention in bipolar disorder impact cognitive functioning? ISBD. Cognitive outcome in bipolar disorder: current status and future directions for targeting treatment, July 16, 2016 2016. Amsterdam, The Netherlands.
63. Berk M, Daglas R, Dandask O, Yucel M, Henry L, Hallam K, et al. Lithium or atypical antipsychotic for maintenance treatment after first episode mania. ISBD, July 14, 2016 2016. Amsterdam, The Netherlands.
64. Geddes JR, Rendell JM, Goodwin GM. Balance: A large simple trial of maintenance treatment for bipolar disorder. World Psychiatry 2002;1:48-51.
65. Geddes JR, Gardiner A, Rendell J, Voysey M, Tunbridge E, Hinds C, et al. Comparative evaluation of quetiapineplus lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in bipolar depression (cequel): A2 x 2 factorial randomised trial. Lancet Psychiatry 2016;3:31-9.
66. Pacchiarotti I, Bond DJ, Baldessarini RJ, Nolen WA, Grunze H, Licht RW, et al. The international society for bipolar disorders (isbd) task force report on antidepressant use in bipolar disorders. Am J Psychiatry 2013;170:1249-62.
67. Sidor MM, Macqueen GM. Antidepressants for the acute treatment of bipolar depression: Asystematic review and meta-Analysis. J Clin Psychiatry 2011;72:156-67.
68. Post RM, Leverich GS, Kupka R, Keck PE Jr., Mcelroy SL, Altshuler LL, et al. Clinical correlates of sustained response to individual drugs used in naturalistic treatment of patients with bipolar disorder. Compr Psychiatry 2016;66:146-56.
69. Strakowski SM, Delbello MP, Fleck DE, Arndt S. The impact of substance abuse on the course of bipolar disorder. Biol Psychiatry 2000;48:477-85.
70. Wilens TE, Biederman J, Kwon A, Ditterline J, ForknerP, Moore H, et al. Risk of substance use disorders in adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 2004;43:1380-6.
71. Goldstein BI, Strober M, Axelson D, Goldstein TR, Gill MK, Hower H, et al. Predictors of first-onset substance use disorders during the prospective course of bipolar spectrum disorders in adolescents. J Am Acad Child Adolesc Psychiatry 2013;52:1026-37.
72. Post RM, Ballenger JC, Putnam FW, Bunney WE Jr. Carbamazepine in alcohol withdrawal syndromes: Relationship to the kindling model. J Clin Psychopharmacol 1983; 3: 204-5.
73. Colton CW, Manderscheid RW. Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Prev Chronic Dis 2006;3:A42.
74. Newcomer JW, Hennekens CH. Severe mental illness and risk of cardiovascular disease. JAMA 2007;298:1794-6.
75. Redlich C, Berk M, Williams LJ, Sundquist J, Sundquist K, Li X. Statin use and risk of depression: Aswedish national cohort study. BMC Psychiatry 2014;14:348.